Functional interactions between B lymphocytes and the innate immune system

Infectious Disorders - Drug Targets

Volumn 12, Issue 3, 2012, Pages 191-199

  Lampropoulou, Vicky ^a   Shen, Ping ^a   Hilgenberg, Ellen ^a   Ries, Stefanie ^a   Opitz, Christian ^a   Fillatreau, Simon ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Autoimmunity; B cells; Cytokines; Humoral immunity; Infections; Innate cells; Neutrophils

Indexed keywords

APRIL PROTEIN; BCG VACCINE; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; RITUXIMAB; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BCG VACCINATION; BIOACCUMULATION; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; EOSINOPHIL; FOLLICULAR DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; INNATE IMMUNITY; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEGAKARYOCYTE; MESENTERY LYMPH NODE; MICROENVIRONMENT; MOLECULAR INTERACTION; MUCOSAL IMMUNITY; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; TUBERCULOSIS;

EID: 84861168501     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/187152612800564374     Document Type: Review

References (93)

1. Lemaitre, B.; Nicolas, E.; Michaut, L.; Reichhart, J. M.; Hoffmann, J. A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell, 1996, 86(6), 973-983.
2. Amanna, I. J.; Carlson, N. E.; Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med., 2007, 357(19), 1903-1915.
3. Manz, R. A.; Thiel, A.; Radbruch, A. Lifetime of plasma cells in the bone marrow. Nature, 1997, 388(6638), 133-134.
4. Banchereau, J.; Steinman, R. M. Dendritic cells and the control of immunity. Nature, 1998, 392(6673), 245-252.
5. Savina, A.; Jancic, C.; Hugues, S.; Guermonprez, P.; Vargas, P.; Moura, I. C.; Lennon-Dumenil, A. M.; Seabra, M. C.; Raposo, G.; Amigorena, S. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell, 2006, 126(1), 205-218.
6. Delamarre, L.; Pack, M.; Chang, H.; Mellman, I.; Trombetta, E. S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science, 2005, 307(5715), 1630-1634.
7. Wykes, M.; Pombo, A.; Jenkins, C.; MacPherson, G. G. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol., 1998, 161(3), 1313-1319.
8. Bergtold, A.; Desai, D. D.; Gavhane, A.; Clynes, R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity, 2005, 23(5), 503-514.
9. Qi, H.; Egen, J. G.; Huang, A. Y.; Germain, R. N. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science, 2006, 312(5780), 1672-1676.
10. Gretz, J. E.; Norbury, C. C.; Anderson, A. O.; Proudfoot, A. E.; Shaw, S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med., 2000, 192(10), 1425-1440.
11. Sainte-Marie, G.; Peng, F. S. Diffusion of a lymph-carried antigen in the fiber network of the lymph node of the rat. Cell Tissue Res., 1986, 245(3), 481-486.
12. Larsen, C. G.; Anderson, A. O.; Appella, E.; Oppenheim, J. J.; Matsushima, K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science, 1989, 243(4897), 1464-1466.
13. Catron, D. M.; Pape, K. A.; Fife, B. T.; van Rooijen, N.; Jenkins, M. K. A protease-dependent mechanism for initiating T-dependent B cell responses to large particulate antigens. J. Immunol., 2010, 184(7), 3609-3617.
14. Berney, C.; Herren, S.; Power, C. A.; Gordon, S.; Martinez-Pomares, L.; Kosco-Vilbois, M. H. A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. J. Exp. Med., 1999, 190(6), 851-860.
15. Garside, P.; Ingulli, E.; Merica, R. R.; Johnson, J. G.; Noelle, R. J.; Jenkins, M. K. Visualization of specific B and T lymphocyte interactions in the lymph node. Science, 1998, 281(5373), 96-99.
16. Gonzalez, S. F.; Lukacs-Kornek, V.; Kuligowski, M. P.; Pitcher, L. A.; Degn, S. E.; Kim, Y. A.; Cloninger, M. J.; Martinez-Pomares, L.; Gordon, S.; Turley, S. J.; Carroll, M. C. Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes. Nat. Immunol., 2010, 11(5), 427-434.
17. Lee, B. O.; Rangel-Moreno, J.; Moyron-Quiroz, J. E.; Hartson, L.; Makris, M.; Sprague, F.; Lund, F. E.; Randall, T. D. CD4 T cellindependent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J. Immunol., 2005, 175(9), 5827-5838.
18. Balazs, M.; Martin, F.; Zhou, T.; Kearney, J. Blood dendritic cells interact with splenic marginal zone B cells to initiate Tindependent immune responses. Immunity, 2002, 17(3), 341-352.
19. Garcia De Vinuesa, C.; Gulbranson-Judge, A.; Khan, M.; O'Leary, P.; Cascalho, M.; Wabl, M.; Klaus, G. G.; Owen, M. J.; MacLennan, I. C. Dendritic cells associated with plasmablast survival. Eur. J. Immunol., 1999, 29(11), 3712-3721.
20. Santiago-Raber, M. L.; Amano, H.; Amano, E.; Fossati-Jimack, L.; Swee, L. K.; Rolink, A.; Izui, S. Evidence that Yaa-induced loss of marginal zone B cells is a result of dendritic cell-mediated enhanced activation. J. Autoimmun., 2010, 34(4), 349-355.
21. Dubois, B.; Vanbervliet, B.; Fayette, J.; Massacrier, C.; Van Kooten, C.; Briere, F.; Banchereau, J.; Caux, C. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med., 1997, 185(5), 941-951.
22. Dubois, B.; Massacrier, C.; Vanbervliet, B.; Fayette, J.; Briere, F.; Banchereau, J.; Caux, C. Critical role of IL-12 in dendritic cellinduced differentiation of naive B lymphocytes. J. Immunol., 1998, 161(5), 2223-2231.
23. Jego, G.; Palucka, A. K.; Blanck, J. P.; Chalouni, C.; Pascual, V.; Banchereau, J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity, 2003, 19(2), 225-234.
24. Ronnblom, L.; Pascual, V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus, 2008, 17(5), 394-399.
25. Bengtsson, A. A.; Sturfelt, G.; Truedsson, L.; Blomberg, J.; Alm, G.; Vallin, H.; Ronnblom, L. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus, 2000, 9(9), 664-671.
26. Teichmann, L. L.; Ols, M. L.; Kashgarian, M.; Reizis, B.; Kaplan, D. H.; Shlomchik, M. J. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity, 2010, 33(6), 967-978.
27. Macpherson, A. J.; Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science, 2004, 303(5664), 1662-1665.
28. Cerutti, A. The regulation of IgA class switching. Nat. Rev. Immunol., 2008, 8(6), 421-434.
29. Tezuka, H.; Abe, Y.; Asano, J.; Sato, T.; Liu, J.; Iwata, M.; Ohteki, T. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity, 2011, 34(2), 247-257.
30. Sato, A.; Hashiguchi, M.; Toda, E.; Iwasaki, A.; Hachimura, S.; Kaminogawa, S. CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J. Immunol., 2003, 171(7), 3684-3690.
31. Iwasaki, A.; Kelsall, B. L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med., 1999, 190(2), 229-239.
32. Massacand, J. C.; Kaiser, P.; Ernst, B.; Tardivel, A.; Burki, K.; Schneider, P.; Harris, N. L. Intestinal bacteria condition dendritic cells to promote IgA production. PLoS One, 2008, 3(7), e2588.
33. Mora, J. R.; Iwata, M.; Eksteen, B.; Song, S. Y.; Junt, T.; Senman, B.; Otipoby, K. L.; Yokota, A.; Takeuchi, H.; Ricciardi-Castagnoli, P.; Rajewsky, K.; Adams, D. H.; von Andrian, U. H. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science, 2006, 314(5802), 1157-1160.
34. Uematsu, S.; Fujimoto, K.; Jang, M. H.; Yang, B. G.; Jung, Y. J.; Nishiyama, M.; Sato, S.; Tsujimura, T.; Yamamoto, M.; Yokota, Y.; Kiyono, H.; Miyasaka, M.; Ishii, K. J.; Akira, S. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol., 2008, 9(7), 769-776.
35. Tezuka, H.; Abe, Y.; Iwata, M.; Takeuchi, H.; Ishikawa, H.; Matsushita, M.; Shiohara, T.; Akira, S.; Ohteki, T. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature, 2007, 448(7156), 929-933.
36. Castigli, E.; Scott, S.; Dedeoglu, F.; Bryce, P.; Jabara, H.; Bhan, A. K.; Mizoguchi, E.; Geha, R. S. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. USA, 2004, 101(11), 3903-3908.
37. von Bulow, G. U.; van Deursen, J. M.; Bram, R. J. Regulation of the T-independent humoral response by TACI. Immunity, 2001, 14(5), 573-582.
38. Pabst, O.; Ohl, L.; Wendland, M.; Wurbel, M. A.; Kremmer, E.; Malissen, B.; Forster, R. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med., 2004, 199(3), 411-416.
39. Macpherson, A. J.; Harris, N. L. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol., 2004, 4(6), 478-485.
40. Fossum, S. The architecture of rat lymph nodes. IV. Distribution of ferritin and colloidal carbon in the draining lymph nodes after footpad injection. Scand. J. Immunol., 1980, 12(5), 433-441.
41. Carrasco, Y. R.; Batista, F. D. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity, 2007, 27(1), 160-171.
42. Phan, T. G.; Gray, E. E.; Cyster, J. G. The microanatomy of B cell activation. Curr. Opin. Immunol., 2009, 21(3), 258-265.
43. Szakal, A. K.; Holmes, K. L.; Tew, J. G. Transport of immune complexes from the subcapsular sinus to lymph node follicles on the surface of nonphagocytic cells, including cells with dendritic morphology. J. Immunol., 1983, 131(4), 1714-1727.
44. Phan, T. G.; Grigorova, I.; Okada, T.; Cyster, J. G. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat. Immunol., 2007, 8(9), 992-1000.
45. Phan, T. G.; Green, J. A.; Gray, E. E.; Xu, Y.; Cyster, J. G. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat. Immunol., 2009, 10(7), 786-793.
46. Junt, T.; Moseman, E. A.; Iannacone, M.; Massberg, S.; Lang, P. A.; Boes, M.; Fink, K.; Henrickson, S. E.; Shayakhmetov, D. M.; Di Paolo, N. C.; van Rooijen, N.; Mempel, T. R.; Whelan, S. P.; von Andrian, U. H. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature, 2007, 450(7166), 110-114.
47. Unanue, E. R.; Cerottini, J. C. The immunogenicity of antigen bound to the plasma membrane of macrophages. J. Exp. Med., 1970, 131(4), 711-725.
48. Suzuki, K.; Grigorova, I.; Phan, T. G.; Kelly, L. M.; Cyster, J. G. Visualizing B cell capture of cognate antigen from follicular dendritic cells. J. Exp. Med., 2009, 206(7), 1485-1493.
49. Sainte-Marie, G.; Peng, F. S. [Distribution of a diffusible tracer in the subcapsular sinus and the cortex of lymph nodes in the rat]. Rev. Can. Biol. Exp., 1982, 41(3), 201-208.
50. Pape, K. A.; Catron, D. M.; Itano, A. A.; Jenkins, M. K. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity, 2007, 26(4), 491-502.
51. Hoehlig, K.; Lampropoulou, V.; Roch, T.; Neves, P.; Calderon-Gomez, E.; Anderton, S. M.; Steinhoff, U.; Fillatreau, S. Immune regulation by B cells and antibodies a view towards the clinic. Adv. Immunol., 2008, 98, 1-38.
52. Harris, D. P.; Haynes, L.; Sayles, P. C.; Duso, D. K.; Eaton, S. M.; Lepak, N. M.; Johnson, L. L.; Swain, S. L.; Lund, F. E. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol., 2000, 1(6), 475-482.
53. Fillatreau, S.; Gray, D.; Anderton, S. M., Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol., 2008, 8(5), 391-397.
54. Anderton, S. M.; Fillatreau, S. Activated B cells in autoimmune diseases: the case for a regulatory role. Nat. Clin. Pract. Rheumatol., 2008, 4(12), 657-666.
55. Fillatreau, S.; Sweenie, C. H.; McGeachy, M. J.; Gray, D.; Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol., 2002, 3(10), 944-950.
56. Mauri, C.; Gray, D.; Mushtaq, N.; Londei, M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med., 2003, 197(4), 489-501.
57. Mizoguchi, A.; Mizoguchi, E.; Takedatsu, H.; Blumberg, R. S.; Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity, 2002, 16(2), 219-230.
58. Neves, P.; Lampropoulou, V.; Calderon-Gomez, E.; Roch, T.; Stervbo, U.; Shen, P.; Kuhl, A. A.; Loddenkemper, C.; Haury, M.; Nedospasov, S. A.; Kaufmann, S. H.; Steinhoff, U.; Calado, D. P.; Fillatreau, S. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity, 2010, 33(5), 777-790.
59. Fillatreau, S., Novel regulatory functions for Toll-like receptoractivated B cells during intracellular bacterial infection. Immunol. Rev., 2011, 240(1), 52-71.
60. Mittrucker, H. W.; Kaufmann, S. H. Immune response to infection with Salmonella typhimurium in mice. J. Leukoc. Biol., 2000, 67(4), 457-463.
61. Buendia, A. J.; Del Rio, L.; Ortega, N.; Sanchez, J.; Gallego, M. C.; Caro, M. R.; Navarro, J. A.; Cuello, F.; Salinas, J. B-celldeficient mice show an exacerbated inflammatory response in a model of Chlamydophila abortus infection. Infect. Immun., 2002, 70(12), 6911-6918.
62. Bosio, C. M.; Elkins, K. L. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cellmediated immunity. Infect. Immun., 2001, 69(1), 194-203.
63. Smelt, S. C.; Cotterell, S. E.; Engwerda, C. R.; Kaye, P. M. B celldeficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J. Immunol., 2000, 164(7), 3681-3688.
64. Maglione, P. J.; Xu, J.; Chan, J. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J. Immunol., 2007, 178(11), 7222-7234.
65. Lampropoulou, V.; Calderon-Gomez, E.; Roch, T.; Neves, P.; Shen, P.; Stervbo, U.; Boudinot, P.; Anderton, S. M.; Fillatreau, S. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol. Rev., 2010, 233(1), 146-161.
66. Eruslanov, E. B.; Lyadova, I. V.; Kondratieva, T. K.; Majorov, K. B.; Scheglov, I. V.; Orlova, M. O.; Apt, A. S. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect. Immun., 2005, 73(3), 1744-1753.
67. Berry, M. P.; Graham, C. M.; McNab, F. W.; Xu, Z.; Bloch, S. A.; Oni, T.; Wilkinson, K. A.; Banchereau, R.; Skinner, J.; Wilkinson, R. J.; Quinn, C.; Blankenship, D.; Dhawan, R.; Cush, J. J.; Mejias, A.; Ramilo, O.; Kon, O. M.; Pascual, V.; Banchereau, J.; Chaussabel, D.; O'Garra, A. An interferon-inducible neutrophildriven blood transcriptional signature in human tuberculosis. Nature, 2010, 466(7309), 973-977.
68. Kondratieva, T. K.; Rubakova, E. I.; Linge, I. A.; Evstifeev, V. V.; Majorov, K. B.; Apt, A. S. B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guerin vaccination against tuberculosis infection in mice. J. Immunol., 2010, 184(3), 1227-1234.
69. Yang, C. W.; Strong, B. S.; Miller, M. J.; Unanue, E. R. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol., 2010, 185(5), 2927-2934.
70. Voog, E.; Morschhauser, F.; Solal-Celigny, P. Neutropenia in patients treated with rituximab. N. Engl. J. Med., 2003, 348(26), 2691-2694; discussion 2691-4.
71. Wolach, O.; Bairey, O.; Lahav, M. Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine (Baltimore), 2010, 89(5), 308-318.
72. Terrier, B.; Ittah, M.; Tourneur, L.; Louache, F.; Soumelis, V.; Lavie, F.; Casadevall, N.; Candon, S.; Hummel, A.; Mariette, X.; Buzyn, A. Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFFinduced B-cell recovery. Haematologica, 2007, 92(2), e20-23.
73. Dunleavy, K.; Hakim, F.; Kim, H. K.; Janik, J. E.; Grant, N.; Nakayama, T.; White, T.; Wright, G.; Kwak, L.; Gress, R.; Tosato, G.; Wilson, W. H. B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood, 2005, 106(3), 795-802.
74. Chaiwatanatorn, K.; Lee, N.; Grigg, A.; Filshie, R.; Firkin, F. Delayed-onset neutropenia associated with rituximab therapy. Br. J. Haematol., 2003, 121(6), 913-918.
75. Granjo, E.; Lima, M.; Fraga, M.; Santos, F.; Magalhaes, C.; Queiros, M. L.; Moreira, I.; Rocha, S.; Silva, A. S.; Rebelo, I.; Quintanilha, A.; Ribeiro, M. L.; Candeias, J.; Orfao, A. Abnormal NK cell lymphocytosis detected after splenectomy: association with repeated infections, relapsing neutropenia, and persistent polyclonal B-cell proliferation. Int. J. Hematol., 2002, 75(5), 484-488.
76. Lampropoulou, V.; Hoehlig, K.; Roch, T.; Neves, P.; Calderon Gomez, E.; Sweenie, C. H.; Hao, Y.; Freitas, A. A.; Steinhoff, U.; Anderton, S. M.; Fillatreau, S. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol., 2008, 180(7), 4763-4773.
77. Moulin, V.; Andris, F.; Thielemans, K.; Maliszewski, C.; Urbain, J.; Moser, M. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B celldeficient mice results in T helper cell type 1 deviation. J. Exp. Med., 2000, 192(4), 475-482.
78. Walzer, T.; Dalod, M.; Robbins, S. H.; Zitvogel, L.; Vivier, E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood, 2005, 106(7), 2252-2258.
79. Jiao, L.; Gao, X.; Joyee, A. G.; Zhao, L.; Qiu, H.; Yang, M.; Fan, Y.; Wang, S.; Yang, X. NK cells promote type 1 T cell immunity through modulating the function of dendritic cells during intracellular bacterial infection. J. Immunol., 2011, 187(1), 401-411.
80. Yoshida, T.; Mei, H.; Dorner, T.; Hiepe, F.; Radbruch, A.; Fillatreau, S.; Hoyer, B. F. Memory B and memory plasma cells. Immunol. Rev., 2010, 237(1), 117-139.
81. Manz, R. A.; Hauser, A. E.; Hiepe, F.; Radbruch, A. Maintenance of serum antibody levels. Annu. Rev. Immunol., 2005, 23, 367-386.
82. Chu, V. T.; Frohlich, A.; Steinhauser, G.; Scheel, T.; Roch, T.; Fillatreau, S.; Lee, J. J.; Lohning, M.; Berek, C. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat. Immunol., 2011, 12(2), 151-159.
83. Juhlin, L.; Michaelsson, G. A new syndrome characterised by absence of eosinophils and basophils. Lancet, 1977, 1(8024), 1233-1235.
84. Winter, O.; Moser, K.; Mohr, E.; Zotos, D.; Kaminski, H.; Szyska, M.; Roth, K.; Wong, D. M.; Dame, C.; Tarlinton, D. M.; Schulze, H.; MacLennan, I. C.; Manz, R. A. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood, 2010, 116(11), 1867-1875.
85. Pistoia, V. Production of cytokines by human B cells in health and disease. Immunol. Today, 1997, 18(7), 343-350.
86. Pistoia, V.; Cozzolino, F.; Rubartelli, A.; Torcia, M.; Roncella, S.; Ferrarini, M. In vitro production of interleukin 1 by normal and malignant human B lymphocytes. J. Immunol., 1986, 136(5), 1688-1692.
87. Zupo, S.; Perussia, B.; Baldi, L.; Corcione, A.; Dono, M.; Ferrarini, M.; Pistoia, V. Production of granulocyte-macrophage colonystimulating factor but not IL-3 by normal and neoplastic human B lymphocytes. J. Immunol., 1992, 148(5), 1423-1430.
88. Kelly-Scumpia, K. M.; Scumpia, P. O.; Weinstein, J. S.; Delano, M. J.; Cuenca, A. G.; Nacionales, D. C.; Wynn, J. L.; Lee, P. Y.; Kumagai, Y.; Efron, P. A.; Akira, S.; Wasserfall, C.; Atkinson, M. A.; Moldawer, L. L. B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med., 2011, 208(8), 1673-1682.
89. Edwards, J. C.; Cambridge, G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat. Rev. Immunol., 2006, 6(5), 394-403.
90. Martin, F.; Chan, A. C. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol., 2006, 24, 467-496.
91. Bar-Or, A.; Fawaz, L.; Fan, B.; Darlington, P. J.; Rieger, A.; Ghorayeb, C.; Calabresi, P. A.; Waubant, E.; Hauser, S. L.; Zhang, J.; Smith, C. H. Abnormal B-cell cytokine responses a trigger of Tcell-mediated disease in MS? Ann. Neurol., 2010, 67(4), 452-461.
92. Monach, P. A.; Nigrovic, P. A.; Chen, M.; Hock, H.; Lee, D. M.; Benoist, C.; Mathis, D. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum., 2010, 62(3), 753-764.
93. Maglione, P. J.; Xu, J.; Casadevall, A.; Chan, J. Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J. Immunol., 2008, 180(5), 3329-3338.